Sign Up to like & get
recommendations!
0
Published in 2020 at "Therapeutic Drug Monitoring"
DOI: 10.1097/ftd.0000000000000829
Abstract: Background: The novel cystic fibrosis transmembrane conductance regulator (CFTR) modulators, ivacaftor, lumacaftor, and tezacaftor, are the first drugs directly targeting the underlying pathophysiological mechanism in cystic fibrosis (CF); however, independent studies describing their pharmacokinetics are…
read more here.
Keywords:
lumacaftor tezacaftor;
method;
ivacaftor;
plasma sputum ... See more keywords